Paris-headquartered life-sciences-focused venture capital investor Sofinnova Partners has held a final close for its flagship early-stage venture healthcare fund Sofinnova Capital IX on €333m.
US conglomerate J.M. Huber has agreed to buy the Italian specialty fertilizers producer
Deal is first full exit from specialist healthcare investor's maiden mid-market fund
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe